Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Chymase inhibitors prepared and tested at Bayer

May 29, 2015

AQP-4 inhibition improves survival of cardiac allografts in mice

May 29, 2015

Endothelial cells overexpressing IL-8 receptors improve experimental restenosis, acute kidney injury

May 26, 2015

Bayer patents chymase inhibitors

May 25, 2015

Bayer presents chymase inhibitors

May 22, 2015

Xeltis completes trial of bioabsorbable matrix in patients with one cardiac ventricle

May 22, 2015

Pluristem's PLX program selected for EMA's Adaptive Pathways pilot project

May 19, 2015

Insmed introduces new prostacyclin analogues

May 14, 2015

Merck & Co. discloses ROM-K channel blockers

May 13, 2015

Roche patents CYP11B2 inhibitors

May 13, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...